David J Speicher

Dr. David J Speicher

Cyrus Scientific Inc, Hamilton, Ontario, Canada
orcid
Founder and Chief Scientific Officer

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 October 2019 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
BABrian P Alcock
Brian P Alcock
ARAmogelang R Raphenya
Amogelang R Raphenya
TLTammy T Y Lau
Tammy T Y Lau
KTKara K Tsang
Kara K Tsang
MBMégane Bouchard
Mégane Bouchard
Andrew McArthurAndrew McArthur
Andrew McArthur
The Comprehensive Antibiotic Resistance Database (CARD; https://card.mcmaster.ca) is a curated resource providing reference DNA and protein sequences, detection models and bioinformatics tools on the molecular basis of bacterial antimicrobial resistance (AMR). CARD focuses on providing high-quality reference data and molecular sequences within a controlled vocabulary, the Antibiotic Resistance Ontology (ARO), designed by the CARD biocuration team to integrate with software development efforts for resistome analysis and prediction, such as CARD’s Resistance Gene Identifier (RGI) software. Since 2017, CARD has expanded through extensive curation of reference sequences, revision of the ontological structure, curation of over 500 new AMR detection models, development of a new classification paradigm and expansion of analytical tools. Most notably, a new Resistomes & Variants module provides analysis and statistical summary of in silico predicted resistance variants from 82 pathogens and over 100 000 genomes. By adding these resistance variants to CARD, we are able to summarize predicted resistance using the information included in CARD, identify trends in AMR mobility and determine previously undescribed and novel resistance variants. Here, we describe updates and recent expansions to CARD and its biocuration process, including new resources for community biocuration of AMR molecular reference data.

1 January 2006 in Journal of Clinical Virology
Verified
Journal Article
Closed access
TST Sloots
T Sloots
PMP Mcerlean
P Mcerlean
DSD Speicher
D Speicher
KAK Arden
K Arden
MNM Nissen
M Nissen
Ian MackayIan Mackay
Ian Mackay

1 January 2016 in Journal of Oral Microbiology
Verified
Journal Article
Open access
PDF file
MPManosha Perera
Manosha Perera
NANezar Al-hebshi
Nezar Al-hebshi
DSDavid J. Speicher
David J. Speicher
IPIrosha Perera
Irosha Perera
NJNewell Johnson
Newell Johnson
Emerging role of bacteria in oral carcinogenesis: a review with special reference to perio-pathogenic bacteria

9 April 2018 in Journal of Dental Research
Verified
Journal Article
Closed access
MPM. Perera
M. Perera
NANezar Al-hebshi
Nezar Al-hebshi
IPI. Perera
I. Perera
DID. Ipe
D. Ipe
GUGlen Ulett
Glen Ulett
NJN.W. Johnson
N.W. Johnson
Results from microbiome studies on oral cancer have been inconsistent, probably because they focused on compositional analysis, which does not account for functional redundancy among oral bacteria. Based on functional prediction, a recent study revealed enrichment of inflammatory bacterial attributes in oral squamous cell carcinoma (OSCC). Given the high relevance of this finding to carcinogenesis, we aimed here to corroborate them in a case-control study involving 25 OSCC cases and 27 fibroepithelial polyp (FEP) controls from Sri Lanka. DNA extracted from fresh biopsies was sequenced for the V1 to V3 region with Illumina’s 2 × 300–bp chemistry. High-quality nonchimeric merged reads were classified to the species level with a prioritized BLASTN-based algorithm. Downstream compositional analysis was performed with QIIME (Quantitative Insights into Microbial Ecology) and linear discriminant analysis effect size, while PICRUSt (Phylogenetic Investigation of Communities by Reconstruction of Unobserved States) was utilized for bacteriome functional prediction. The OSCC tissues tended to have lower species richness and diversity. Genera Capnocytophaga, Pseudomonas , and Atopobium were overrepresented in OSCC, while Lautropia, Staphylococcus , and Propionibacterium were the most abundant in FEP. At the species level, Campylobacter concisus, Prevotella salivae, Prevotella loeschii , and Fusobacterium oral taxon 204 were enriched in OSCC, while Streptococcus mitis, Streptococcus oral taxon 070, Lautropia mirabilis , and Rothia dentocariosa among others were more abundant in FEP. Functionally, proinflammatory bacterial attributes, including lipopolysaccharide biosynthesis and peptidases, were enriched in the OSCC tissues. Thus, while the results in terms of species composition significantly differed from the original study, they were consistent at the functional level, substantiating evidence for the inflammatory nature of the bacteriome associated with OSCC.

1 January 2017 in Journal of Oral Microbiology
Verified
Journal Article
Open access
MPManosha Perera
Manosha Perera
NANezar Al-hebshi
Nezar Al-hebshi
IPIrosha Perera
Irosha Perera
DIDeepak Ipe
Deepak Ipe
GUGlen Ulett
Glen Ulett
NJNewell W. Johnson
Newell W. Johnson
The aim of this study was to characterize the mycobiome associated with oral squamous-cell carcinoma (OSCC). DNA was extracted from 52 tissue biopsies (cases: 25 OSCC; controls: 27 intra-oral fibro-epithelial polyps [FEP]) and sequenced for the fungal internal transcribed spacer 2 region using Illumina™ 2 x300bp chemistry. Merged reads were classified to species level using a BLASTN-algorithm with UNITE’s named species sequences as reference. Downstream analyses were performed using QIIME™ and linear discriminant analysis effect size. A total of 364 species representing 160 genera and two phyla (Ascomycota and Basidiomycota) were identified, with Candida and Malassezia making up 48% and 11% of the average mycobiome, respectively. However, only five species and four genera were detected in ≥50% of the samples. The species richness and diversity were significantly lower in OSCC. Genera Candida, Hannaella, and Gibberella were overrepresented in OSCC; Alternaria and Trametes were more abundant in FEP. Species-wise, Candida albicans, Candida etchellsii, and a Hannaella luteola–like species were enriched in OSCC, while a Hanseniaspora uvarum–like species, Malassezia restricta, and Aspergillus tamarii were the most significantly abundant in FEP. In conclusion, a dysbiotic mycobiome dominated by C. albicans was found in association with OSCC, a finding worth further investigation.

19 August 2022 in Biomedicines
Verified
Journal Article
Open access
PDF file
JKJason Knapp
Jason Knapp
JKJulia Kakish
Julia Kakish
Byram BridleByram Bridle
Byram Bridle
DSDavid J. Speicher
David J. Speicher
The temperature of a solid tumor is often dissimilar to baseline body temperature and, compared to healthy tissues, may be elevated, reduced, or a mix of both. The temperature of a tumor is dependent on metabolic activity and vascularization and can change due to tumor progression, treatment, or cancer type. Despite the need to function optimally within temperature-variable tumors, oncolytic viruses (OVs) are primarily tested at 37 °C in vitro. Furthermore, animal species utilized to test oncolytic viruses, such as mice, dogs, cats, and non-human primates, poorly recapitulate the temperature profile of humans. In this review, we discuss the importance of temperature as a variable for OV immunotherapy of solid tumors. Accumulating evidence supports that the temperature sensitivity of OVs lies on a spectrum, with some OVs likely hindered but others enhanced by elevated temperatures. We suggest that in vitro temperature sensitivity screening be performed for all OVs destined for the clinic to identify potential hinderances or benefits with regard to elevated temperature. Furthermore, we provide recommendations for the clinical use of temperature and OVs.